Skip to main navigation Skip to search Skip to main content

The novel inhaled glucocorticoid receptor agonist GW870086X protects against adenosine-induced bronchoconstriction in asthma

  • Brian R Leaker
  • , Brian O'Connor
  • , D Singh
  • , Peter J Barnes
  • Respiratory Clinical Trials Ltd
  • Imperial College London

Research output: Contribution to journal › Article › peer-review

Original languageEnglish
Pages (from-to)501-2.e6
JournalThe Journal of allergy and clinical immunology
Volume136
Issue number2
DOIs
Publication statusPublished - Aug 2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Adenosine Monophosphate
  • Administration, Inhalation
  • Adolescent
  • Adult
  • Anti-Asthmatic Agents
  • Asthma
  • Bronchial Provocation Tests
  • Bronchoconstriction
  • Double-Blind Method
  • Gene Expression
  • Humans
  • Hydrocortisone
  • Male
  • Middle Aged
  • Osteocalcin
  • Receptors, Glucocorticoid
  • Steroids
  • Letter
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

Cite this